Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Combination of Cisplatin, Cetuximab and Temsirolimus in Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck

This study has been terminated.
Sponsor:
Collaborator:
National Comprehensive Cancer Network
Information provided by:
University of Tennessee Cancer Institute
ClinicalTrials.gov Identifier:
NCT01015664
First received: November 17, 2009
Last updated: December 13, 2012
Last verified: December 2012
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Study Completion Date: December 2012
  Primary Completion Date: December 2012 (Final data collection date for primary outcome measure)